Dr. Nebiyu Abiy Eshetu, MD

Dr. Eshetu practices at SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care.

Dr. Eshetu's NPI, 1407275357, was assigned on April 8, 2014. Dr. Eshetu holds Maryland license D0084914.

Dr. Eshetu's primary practice is SSM Health Saint Louis University Hospital, at 1201 S Grand Blvd, Saint Louis, MO 63104 in St. Louis City. The practice phone is (314) 257-8000.

Dr. Eshetu's primary practice is SSM Health Saint Louis University Hospital in Saint Louis, Missouri, part of SSM Health Care. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Eshetu to 2 more medical groups, 1 behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eshetu practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Eshetu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Eshetu's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 374 Medicare services from Dr. Eshetu across 7 procedure codes in 2024, for 132 Medicare patients. Medicare paid $25,841 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 132 Medicare patients who saw Dr. Eshetu in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eshetu's median patient age at 70, with 43% women.

In 2024, Dr. Eshetu wrote 255 Medicare Part D claims for 64 patients. 82% of them were for generic drugs. CMS names the drug for 78 of them, across 5 drugs with 11 or more claims each, at $14,029 in total drug cost. In 2023, CMS named 314 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Eshetu for performance year 2024, reported as part of a group. Dr. Eshetu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 198 general payments to Dr. Eshetu from 29 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $614.